Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Masato, Shino"'
Autor:
Atsushi Musha, Nobuteru Kubo, Hidemasa Kawamura, Naoko Okano, Hiro Sato, Kohei Okada, Kento Tomizawa, Norichika Ota, Akiko Adachi, Masato Shino, Osamu Nikkuni, Shota Ida, Katsuyuki Shirai, Jun‐ichi Saitoh, Satoshi Yokoo, Kazuaki Chikamatsu, Tatsuya Ohno
Publikováno v:
Cancer Reports, Vol 6, Iss 7, Pp n/a-n/a (2023)
Abstract Background Carbon‐ion radiotherapy (C‐ion RT) is effective for head and neck mucosal melanoma (HN‐MM), including radioresistant mucosal melanoma. Melanoma also responds effectively to immune checkpoint inhibitors (ICIs). Data on the ef
Externí odkaz:
https://doaj.org/article/6cbe1720c61641cab04ce897690fadd6
Autor:
Hiroe Tada, Hideyuki Takahashi, Reika Kawabata-Iwakawa, Yurino Nagata, Miho Uchida, Masato Shino, Shota Ida, Ikko Mito, Toshiyuki Matsuyama, Kazuaki Chikamatsu
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract The emergence of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Biomarkers of the therapeutic efficacy of ICIs have been extensively investiga
Externí odkaz:
https://doaj.org/article/b28b2d63a4804c69a542aee6503715fb
Autor:
Yukihiro Takayasu, Nobuteru Kubo, Masato Shino, Osamu Nikkuni, Shota Ida, Atsushi Musha, Katsumasa Takahashi, Junko Hirato, Katsuyuki Shirai, Jun‐ichi Saitoh, Satoshi Yokoo, Kazuaki Chikamatsu, Tatsuya Ohno, Takashi Nakano, for the Working Group on Head and Neck Tumors
Publikováno v:
Cancer Medicine, Vol 8, Iss 17, Pp 7227-7235 (2019)
Abstract This study aimed to evaluate the efficacy of carbon‐ion radiotherapy in combination with chemotherapy using dacarbazine, nimustine, and vincristine (DAV therapy) in mucosal melanoma. Twenty‐one patients with clinically localized mucosal
Externí odkaz:
https://doaj.org/article/2b6a734a2c474461be926670ea000ca2
Autor:
Naoto Osu, Atsushi Musha, Hikaru Yumisaki, Kohei Okada, Nobuteru Kubo, Naoko Okano, Yukihiko Takayasu, Masato Shino, Osamu Nikkuni, Shota Ida, Hidemasa Kawamura, Kazuaki Chikamatsu, Tatsuya Ohno
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 19, p 5905 (2022)
External auditory canal (EAC) cancer is a rare disease for which there are no adequate evidence-based treatment strategies. Radiotherapy is often used as the initial treatment to preserve the organ. This study aimed to elucidate the efficacy of radio
Externí odkaz:
https://doaj.org/article/b7cd4b1e437d42aea299260fd6c3aef8
Publikováno v:
Nihon Kikan Shokudoka Gakkai Kaiho. 73:216-221
Autor:
Osamu Nikkuni, Nobuteru Kubo, Satoshi Yokoo, Masato Shino, Shota Ida, Katsuyuki Shirai, Neck Tumors, Tatsuya Ohno, Takuya Kaminuma, Hiro Sato, Naoko Okano, Masaru Ogawa, Jun-ichi Saitoh, Hidemasa Kawamura, Yukihiro Takayasu, Kazuaki Chikamatsu, Atsushi Musha
Publikováno v:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 34:280-286
Objective Data on the long-term outcomes of carbon-ion radiotherapy for non-squamous cell carcinomas are rare. Gunma University has been utilizing carbon-ion radiotherapy as a treatment for head and neck cancer since 2010. This study aimed to evaluat
Autor:
Atsushi, Musha, Nobuteru, Kubo, Hidemasa, Kawamura, Naoko, Okano, Hiro, Sato, Kohei, Okada, Naoto, Osu, Hikaru, Yumisaki, Akiko, Adachi, Yukihiro, Takayasu, Masato, Shino, Osamu, Nikkuni, Shota, Ida, Katsuyuki, Shirai, Jun-Ichi, Saitoh, Satoshi, Yokoo, Kazuaki, Chikamatsu, Tatsuya, Ohno
Publikováno v:
Anticancer Research. 42:1439-1446
Bone and soft-tissue sarcomas of the head and neck have very poor prognoses. This prospective study aimed to investigate the efficacy and safety of carbon-ion radiotherapy (C-ion RT) for bone and soft-tissue sarcoma of the head and neck.The present s
Publikováno v:
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY. 32:53-59
Autor:
Tetsunari Oyama, Hideyuki Takahashi, Shota Ida, Yurino Nagata, Kei Masuda, Ikko Mito, Hideki Sezutsu, Toshiyuki Matsuyama, Masato Shino, Kazuaki Chikamatsu, Shigeki Takeda, Miho Uchida, Ken-Ichiro Tatematsu, Kanae Yamada, Hiroe Tada
Publikováno v:
Cancer Immunology, Immunotherapy. 71:851-863
Cancer immunotherapy using immune checkpoint inhibitors (ICIs) has been recognized as a novel therapeutic option for head and neck squamous cell carcinoma (HNSCC). However, only approximately 20-30% of patients with recurrent/metastatic (R/M) HNSCC b
Publikováno v:
Koutou (THE LARYNX JAPAN). 33:37-41